Form 4 for LH Labcorp
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-04 · accession 0001127602-22-003651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-08 | 2022-02-04 | LH | Caveney Brian J | EVP, Pres of Diagnostics | M - OptEx | — | +560 | 10.1K | +6% | — |
| D | 2022-02-08 | 2022-02-04 | LH | Caveney Brian J | EVP, Pres of Diagnostics | F - Tax | $277.48 | -165 | 9,912 | -2% | -$45.8K |
| D | 2022-02-08 | 2022-02-04 | LH | Caveney Brian J | EVP, Pres of Diagnostics | M - OptEx | $0.00 | -560 | 6,095 | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-04 | M | A | 560 | — | 10,076.91 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| 2 | Common | Common Stock | 2022-02-04 | F | D | 165 | $277.48 | 9,911.91 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-02-04 | M | D | 560 | $0.00 | 6,095 | D | — · — to — | 560 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021. |